Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.50
Delayed Data
As of Feb 27
 +0.41 / +37.61%
Today’s Change
0.51
Today|||52-Week Range
4.14
+114.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Operating ActivitiesNet Income / Starting Line-3.6M-4.9M-4.8M-4.9M
 
 
 
 
 
Depreciation12.0K23.0K23.0K69.0K
 
 
 
 
 
Total Other Cash Flow211.0K234.0K227.0K223.0K
 
 
 
 
 
Funds From Operations-3.3M-4.6M-4.6M-4.6M
 
 
 
 
 
Funds From/For Other Operating Expenses2.0M114.0K-461.0K1.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.4M-4.7M-4.1M-6.2M
 
 
 
 
 
 
InvestingCapital Expenditures-109.0K-31.0K-34.0K-237.0K
 
 
 
 
 
Other Investing - Sources132.0K96.0K96.0K96.0K
 
 
 
 
 
Net Cash Flow Investing23.0K65.0K62.0K-141.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale2.0M1.7M9.3M0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total-50.0K-50.0K-50.0K-50.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing2.0M1.6M9.2M-50.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash63.0K43.0K102.0K-351.0K
 
 
 
 
 
 
Net Change In Cash-3.4M-3.0M5.2M-6.4M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account